JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice

por Honap, Sailish, Irving, Peter M., Samaan, Mark A.
Publicado 2023

Golimumab in the treatment of ulcerative colitis

por Cunningham, Georgina, Samaan, Mark A., Irving, Peter M.
Publicado 2019

Review article: guide to tofacitinib dosing in patients with ulcerative colitis

por Irving, Peter M., Leung, Yvette, Dubinsky, Marla C.
Publicado 2022

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?

por Luber, Raphael P., Honap, Sailish, Cunningham, Georgina, Irving, Peter M.
Publicado 2019

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis

por Dart, Robin J, Samaan, Mark A, Powell, Nick, Irving, Peter M
Publicado 2017

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study

por Irving, Peter M, de Lusignan, Simon, Tang, Daniel, Nijher, Monica, Barrett, Kevin
Publicado 2021

Regulatory T-cell therapy in Crohn’s disease: challenges and advances

por Clough, Jennie N, Omer, Omer S, Tasker, Scott, Lord, Graham M, Irving, Peter M
Publicado 2020

Biologic therapies for Crohn’s disease: optimising the old and maximising the new

por Samaan, Mark, Campbell, Samantha, Cunningham, Georgina, Tamilarasan, Aravind Gokul, Irving, Peter M., McCartney, Sara
Publicado 2019

Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists

por Raine, Tim, Gkini, Maria Angeliki, Irving, Peter M., Kaul, Arvind, Korendowych, Eleanor, Laws, Philip, Foulkes, Amy C.
Publicado 2021

Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms

por Wilson, Bridgette, Eyice, Özge, Koumoutsos, Ioannis, Lomer, Miranda C., Irving, Peter M., Lindsay, James O., Whelan, Kevin
Publicado 2021

Nutrient, Fibre, and FODMAP Intakes and Food-related Quality of Life in Patients with Inflammatory Bowel Disease, and Their Relationship with Gastrointestinal Symptoms of Differing...

por Cox, Selina R, Clarke, Hazel, O’Keeffe, Majella, Dubois, Patrick, Irving, Peter M, Lindsay, James O, Whelan, Kevin
Publicado 2021

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease

por Reinisch, Walter, Gecse, Krisztina, Halfvarson, Jonas, Irving, Peter M, Jahnsen, Jørgen, Peyrin-Biroulet, Laurent, Rogler, Gerhard, Schreiber, Stefan, Danese, Silvio
Publicado 2020

Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel u...

por Dubinsky, Marla C., Irving, Peter M., Panaccione, Remo, Naegeli, April N., Potts-Bleakman, Alison, Arora, Vipin, Shan, Mingyang, Travis, Simon
Publicado 2022

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report

por Merrick, Blair, Tamilarasan, Aravind Gokul, Luber, Raphael, Yong, Patrick F. K., Cheent, Kuldeep, Irving, Peter M., Meda, Manjula, Goldenberg, Simon D.
Publicado 2022

Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization an...

por Probert, Christopher SJ, Sebastian, Shaji, Gaya, Daniel R, Hamlin, P John, Gillespie, Gillian, Rose, Anita, Tate, Helen, Wheeler, Colin, Irving, Peter M
Publicado 2018

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study

por Cummings, Fraser, Gaya, Daniel R., Levison, Scott, Subramanian, Sreedhar, Owen, Glynn, Rathmell, Anna, Glen, Fiona, Demuth, Dirk, Meadowcroft, Simon, Irving, Peter M.
Publicado 2019

Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis

por Sandborn, William J, Armuzzi, Alessandro, Liguori, Giuseppina, Irving, Peter M, Sharara, Ala I, Mundayat, Rajiv, Lawendy, Nervin, Woolcott, John C, Danese, Silvio
Publicado 2021

Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial

por D’Haens, Geert, Reinisch, Walter, Schreiber, Stefan, Cummings, Fraser, Irving, Peter M., Ye, Byong Duk, Kim, Dong-Hyeon, Yoon, SangWook, Ben-Horin, Shomron
Publicado 2023

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study

por Luber, Raphael P, Duff, Alexa, Pavlidis, Polychronis, Honap, Sailish, Meade, Susanna, Ray, Shuvra, Anderson, Simon H, Mawdsley, Joel, Samaan, Mark A, Irving, Peter M
Publicado 2022

Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel Disease

por Omer, Omer S., Hertweck, Arnulf, Roberts, Luke B., Lo, Jonathan W., Clough, Jennie N., Jackson, Ian, Pantazi, Eirini D., Irving, Peter M., MacDonald, Tom T., Pavlidis, Polychronis, Jenner, Richard G., Lord, Graham M.
Publicado 2022